Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jul 11;117(2):157-300.
doi: 10.1038/bjc.2017.176. Epub 2017 Jun 22.

Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?

N LeVasseur  1 , S K Chia  1
Affiliations
Editorial

Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter?

N LeVasseur et al. Br J Cancer. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

References

    1. Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L (2003) Randomized trial of dose dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as post-operative adjuvant treatment of node positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21: 1431–1439. - PubMed
    1. Del Mastro L, Bruzzi P, Nicolo G, Cavazzini G, Contu A, D’Amico M, Lavarello A, Testore F, Castagneto B, Aitini E, Perdelli L, Bighin C, Rosso R, Venturini M (2005) HER-2 expression and efficacy of dose dense anthracycline containing adjuvant chemotherapy in breast cancer patients. Br J Cancer 93: 7–14. - PMC - PubMed
    1. Earl HM, Hiller L, Dunn JA, Bathers S, Harvey P, Stanley A, Grieve RJ, Agrawal RK, Fernando IN, Brunt AM, McAdam K, O’Reilly S, Rea DW, Spooner D, Poole CJ (2008) NEAT: National Epirubicin Adjuvant Trial-toxicity, delivered dose intensity and quality of life. Br J Cancer 21: 1226–1231. - PMC - PubMed
    1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687–1717. - PubMed
    1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379: 432–444. - PMC - PubMed